pillbase.ru

Caprelsa

Active substance: vandetanib

vandetanib

Centralised EU authorisationActive

Marketing holder: Esteve Pharmaceuticals, S.A.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • CAPRELSA
    TABLET, FILM COATED · VANDETANIB 300 mg/1
    58468-7840
    Genzyme Corporation
  • CAPRELSA
    TABLET, FILM COATED · VANDETANIB 100 mg/1
    58468-7820
    Genzyme Corporation
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-4c98-70e7-bcba-2ee1e95e3f6d,01a12098-db10-78d5-809c-ce77c5c25e2c;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/002315
Registration status
Active
ATC code
L01XE
Sources
  • product · EMA · EMEA/H/C/002315 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/002315 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/002315 · Verified 2026-10-09